CareDx (CDNA) Wānana Kūʻai Kūʻai
CareDx
Hōʻoia AI: CDNA
Hoʻopuka ka AI i kahi kumukūʻai pahuhopu no ka lā kālepa aʻe, ka hopena pule a me ka hopena mahina. Hoʻomākaukau ʻia ka hoʻololi mai ka kumukūʻai hou loa. He helnau kūlana helu wale nō kēia, ʻaʻole he ʻōlelo aʻoaʻo hoʻopukapuka.
Kumukūʻai ma luna o nā mahina 6 i hala
Hōʻike ʻo Premium i nā pahuhopu kumukūʻai o ka AI no 1 lā, 1 pule a me 1 mahina no kēia a me nā stock ʻē aʻe.
Wehe iā Premium🔒 Moʻolelo hōʻike wānana
The forecast track record — every past forecast next to the actual close — is part of Premium.
Wehe iā PremiumE pili ana i kēia Hui
CareDx develops molecular tests for assessing the immune system and treating kidney and heart diseases. The company specializes in transplantation, offering tests to evaluate donor-recipient compatibility for organ transplants, monitor graft status, and detect signs of rejection. CareDx also develops diagnostic tests for cardiomyopathies and hereditary diseases. The company collaborates with clinics worldwide.
